Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Elizabeth Garrett‐Mayer, Susan Halabi, Pam K. Mangat, Patricia Rich, Eugene R. Ahn, Seungjean Chai, Andrew L. Rygiel, Olufunlayo Osayameh, Kaitlyn R. Antonelli, Samiha Islam, Suanna S. Bruinooge, Richard L. Schilsky
Topics & Concepts
MedicineSunitinibInternal medicineOncologyClinical endpointColorectal cancerTyrosine-kinase inhibitorAdverse effectResponse Evaluation Criteria in Solid TumorsCohortClinical trialPhases of clinical researchCancerColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsAdvanced Breast Cancer Therapies